Reykjavik, Iceland, 7 May 2007 ― Actavis Group (OMX: ACT), the international generic pharmaceuticals company, announces that it will host a conference call on Wednesday 9 May at 13.30 GMT/ 14.30 BST/ 09.30 ET for European and US investors to discuss earnings. Actavis' earnings press release will be made available after the close of the OMX Stock Exchange in Iceland on Tuesday 8 May 2007, around 17.00 GMT Live conference call for analysts and investors: Robert Wessman, President and Chief Executive Officer and Mark Keatley CFO, will host the live Conference Call for analysts and investors, the details of which are as follows: Conference Call for European and US Investors Time of call: 13.30 GMT/ 14.30 BST/ 09.30 ET UK Dial in: + 44 (0)20 7806 1960 US / Canada dial in: + 1 718 354 1390 Password/Conf ID: Actavis Q1 Results A presentation accompanying the conference call will be available on Actavis' website at www.actavis.com, in the investor relations section, one hour before the call. Replay: A replay of the presentation will be available on Actavis' website, and by telephone until 15 May. Details are as follows: UK: +44 (0)20 7806 1970 (Pin: 8854546#) US / Canada: + 1 718 354 1112(Pin: 8854546#) For more information, please contact Halldor Kristmannsson, Director of Corporate Communications, tel. +354 535 2325, +354 840 3425, email: hkristmannsson@actavis.com About Actavis Group Actavis is one of the world's leading generic pharmaceutical companies specializing in the development, manufacture and sale of generic pharmaceuticals. Based in Iceland, the company has operations in over 30 countries, with 11,000 employees. The company's market capitalization is approximately EUR3bn (US$3.8 billion) and is listed in the Iceland Stock Exchange. Actavis expects 2007 sales to total EUR1.6bn, with approximately one-third of these sales coming from the United States, the company's single largest market.